Cardinal Health (NYSE:CAH) Price Target Raised to $134.00 at UBS Group

Cardinal Health (NYSE:CAH) had its price objective lifted by analysts at UBS Group from $125.00 to $134.00 in a research note issued to investors on Tuesday, Benzinga reports. The brokerage currently has a “buy” rating on the stock. UBS Group’s price objective indicates a potential upside of 19.79% from the stock’s previous close.

Other equities research analysts have also recently issued reports about the stock. Deutsche Bank Aktiengesellschaft increased their target price on shares of Cardinal Health from $115.00 to $119.00 and gave the company a “hold” rating in a research report on Friday, August 16th. JPMorgan Chase & Co. increased their price objective on shares of Cardinal Health from $111.00 to $123.00 and gave the company a “neutral” rating in a report on Wednesday, August 21st. Evercore ISI boosted their target price on Cardinal Health from $105.00 to $115.00 and gave the stock an “in-line” rating in a report on Thursday, August 15th. Robert W. Baird increased their price target on Cardinal Health from $130.00 to $137.00 and gave the company an “outperform” rating in a report on Thursday, August 15th. Finally, StockNews.com upgraded Cardinal Health from a “buy” rating to a “strong-buy” rating in a research report on Thursday, October 17th. One investment analyst has rated the stock with a sell rating, four have given a hold rating, seven have assigned a buy rating and one has given a strong buy rating to the stock. According to MarketBeat, the stock presently has a consensus rating of “Moderate Buy” and a consensus price target of $120.18.

Cardinal Health Price Performance

NYSE CAH traded down $0.46 on Tuesday, hitting $111.86. The company had a trading volume of 84,935 shares, compared to its average volume of 2,073,445. The company has a market capitalization of $27.25 billion, a PE ratio of 49.72, a PEG ratio of 1.57 and a beta of 0.60. Cardinal Health has a 12-month low of $90.19 and a 12-month high of $116.05. The company’s fifty day moving average price is $111.00 and its 200-day moving average price is $103.91.

Cardinal Health (NYSE:CAH) last released its quarterly earnings results on Wednesday, August 14th. The company reported $1.84 earnings per share for the quarter, topping the consensus estimate of $1.74 by $0.10. Cardinal Health had a net margin of 0.37% and a negative return on equity of 54.85%. The firm had revenue of $59.87 billion during the quarter, compared to the consensus estimate of $58.74 billion. During the same quarter in the prior year, the firm earned $1.55 EPS. The company’s revenue for the quarter was up 12.1% on a year-over-year basis. On average, sell-side analysts anticipate that Cardinal Health will post 7.61 EPS for the current year.

Insider Buying and Selling at Cardinal Health

In other news, insider Michelle D. Greene sold 4,000 shares of the business’s stock in a transaction dated Monday, August 19th. The stock was sold at an average price of $108.85, for a total transaction of $435,400.00. Following the completion of the transaction, the insider now directly owns 19,242 shares of the company’s stock, valued at approximately $2,094,491.70. The trade was a 0.00 % decrease in their ownership of the stock. The sale was disclosed in a filing with the SEC, which can be accessed through the SEC website. In other news, insider Jessica L. Mayer sold 16,573 shares of the firm’s stock in a transaction dated Wednesday, August 21st. The stock was sold at an average price of $109.39, for a total transaction of $1,812,920.47. Following the sale, the insider now owns 75,971 shares of the company’s stock, valued at approximately $8,310,467.69. This trade represents a 0.00 % decrease in their position. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through the SEC website. Also, insider Michelle D. Greene sold 4,000 shares of the company’s stock in a transaction that occurred on Monday, August 19th. The shares were sold at an average price of $108.85, for a total value of $435,400.00. Following the completion of the transaction, the insider now directly owns 19,242 shares of the company’s stock, valued at $2,094,491.70. This trade represents a 0.00 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders have sold 113,963 shares of company stock valued at $12,379,980 in the last quarter. Corporate insiders own 0.15% of the company’s stock.

Institutional Investors Weigh In On Cardinal Health

A number of institutional investors and hedge funds have recently made changes to their positions in CAH. Eastern Bank purchased a new position in shares of Cardinal Health in the 3rd quarter valued at approximately $25,000. Cultivar Capital Inc. purchased a new position in shares of Cardinal Health during the 2nd quarter worth approximately $27,000. LRI Investments LLC acquired a new position in shares of Cardinal Health in the first quarter worth $32,000. Ashton Thomas Private Wealth LLC acquired a new position in Cardinal Health in the 2nd quarter valued at about $29,000. Finally, Palisade Asset Management LLC purchased a new position in shares of Cardinal Health during the first quarter valued at approximately $34,000. 87.17% of the stock is owned by hedge funds and other institutional investors.

Cardinal Health Company Profile

Cardinal Health, Inc operates as a healthcare services and products company in the United States, Canada, Europe, Asia, and internationally. It provides customized solutions for hospitals, healthcare systems, pharmacies, ambulatory surgery centers, clinical laboratories, physician offices, and patients in the home.